https://www.selleckchem.com/pr....oducts/bms-986165.ht
10 g) twin-screw hot melt extruder. The chosen parent reagents have shown sufficiently strong reactivity and resulted in successful and complete conversion to THEDES while in the presence of PCL, during the extrusion process. The formulated THEDES-PCL matrix exhibited significantly improved onset of drug release followed by a controlled delivery of MET over a total 7-day period in SVF, proving itself as a viable alternative to oral therapy.Despite the fact that atrovastatin (At) is being one of the bestselling statins used to prevent
Like
Comment
Share
